These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 563539

  • 41. Pharmacological evidence for a vasodilator receptor to serotonin in the nasal vessels of the dog.
    Vargaftig BB, Lefort J.
    Eur J Pharmacol; 1974 Feb; 25(2):216-25. PubMed ID: 4435025
    [No Abstract] [Full Text] [Related]

  • 42. 5-Hydroxytryptamine receptors. Contractile activity and mode of inhibition by methysergide in mammalian intracranial and extracranial vessels.
    Lamar JC, Edvinsson L.
    Arch Int Pharmacodyn Ther; 1980 Feb; 243(2):245-54. PubMed ID: 7377898
    [Abstract] [Full Text] [Related]

  • 43. Evaluation of drugs applicable to treatment of migraine in the cranial circulation of the monkey.
    Lance JW, Spira PJ, Mylecharane EJ, Lord GD, Duckworth JW.
    Res Clin Stud Headache; 1978 Feb; 6():13-8. PubMed ID: 103151
    [No Abstract] [Full Text] [Related]

  • 44. Functional bases for a central serotonergic involvement in classic migraine: a speculative view.
    MacKenzie ET, Edvinsson L, Scatton B.
    Cephalalgia; 1985 Jun; 5(2):69-78. PubMed ID: 3893731
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. 5-Hydroxtryptamine1D receptor agonism predicts antimigraine efficacy.
    Deliganis AV, Peroutka SJ.
    Headache; 1991 Apr; 31(4):228-31. PubMed ID: 1646776
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Pizotifen, an antimigraine drug with venoconstrictor activity in vivo.
    Müller-Schweinitzer E.
    J Cardiovasc Pharmacol; 1986 Apr; 8(4):805-10. PubMed ID: 2427822
    [Abstract] [Full Text] [Related]

  • 52. Regional differences in the responsiveness of isolated arteries from cattle, dog and man.
    Müller-Schweinitzer E, Weidmann H.
    Agents Actions; 1977 Sep; 7(3):383-9. PubMed ID: 596322
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. The pharmacology of ergotamine and dihydroergotamine.
    Silberstein SD.
    Headache; 1997 Sep; 37 Suppl 1():S15-25. PubMed ID: 9009470
    [Abstract] [Full Text] [Related]

  • 55. Serotonin antagonists.
    Anthony M.
    Aust N Z J Med; 1984 Dec; 14(6):888-95. PubMed ID: 6398056
    [Abstract] [Full Text] [Related]

  • 56. Pharmacological analysis of 5-hydroxytryptamine receptors in isolated intracranial and extracranial vessels of cat and man.
    Edvinsson L, Hardebo JE, Owman C.
    Circ Res; 1978 Jan; 42(1):143-51. PubMed ID: 618595
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Effect of methysergide and dihydroergotamine on Schistosoma mansoni.
    Hillman GR, Olsen NJ, Senft AW.
    J Pharmacol Exp Ther; 1974 Mar; 188(3):529-35. PubMed ID: 4816326
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. The way to serotonergic use and abuse in migraine.
    Nicolodi M, Del Bianco PL, Sicuteri F.
    Int J Clin Pharmacol Res; 1997 Mar; 17(2-3):79-84. PubMed ID: 9403359
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.